Insulin resistance as the core defect in type 2 diabetes mellitus.
about
Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsTwo membrane-associated tyrosine phosphatase homologs potentiate C. elegans AKT-1/PKB signalingDiabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primatesThe effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41Does the brain shrink as the waist expands?Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes.Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.Weight considerations in pharmacotherapy for type 2 diabetesSex differences in type 2 diabetes: focus on disease course and outcomesApelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulinRedox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targetsMolecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitusAnti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice.AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats.Resistin: molecular history and prognosis.Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.Sleep respiratory disorders and clinical profile in patients with type 2 diabetes mellitus.Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity.Association of TNF-α 308 G/A Polymorphism With Type 2 Diabetes: A Case-Control Study in the Iranian Kurdish Ethnic Group.Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.Slowing cardiovascular disease progression in African-American patients: diabetes management.Heart failure management in African Americans: meeting the challenge.The diabetic heart: too sweet for its own good?The clinical biochemistry of obesity.The metabolic syndrome: an emerging risk state for cardiovascular disease.Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.The Metabolic Syndrome in Patients With Severe Mental Illnesses4-Hydroxyisoleucine improves hepatic insulin resistance by restoring glycogen synthesis in vitroThe AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes.Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L.Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.Prevalence of obstructive sleep apnoea in men with type 2 diabetes.Fermentation of Green Tea with 2% Aquilariae lignum Increases the Anti-Diabetic Activity of Green Tea Aqueous Extracts in the High Fat-Fed Mouse.The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.Glycaemic index and metabolic disease risk.Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose.Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo.
P2860
Q24652687-CBA2898C-7CF7-41B2-B212-E2A2DCFC327CQ27315422-9B8629A9-EF66-4AA9-B691-60FB9BFEF5D6Q28543410-DC24D972-771F-4139-ABEE-A5A278E06EB0Q28588479-F2185FBE-4F97-4DFB-A712-1B9D7776FDC3Q30809609-A8C9E5A3-300F-4812-ABAD-F060F4BB7A8AQ33675056-CB028430-1F16-4FB3-9F18-E20D75FFA724Q33860786-E1856785-6B13-4E09-8F4C-5CDD4756A650Q34159414-4F2F3745-C9DB-4782-A579-A51504B6C358Q34229975-8D0E01F2-F661-4693-8700-752FE3C1E8BEQ34600236-07C1DF20-74A0-4DBF-B559-ABDC3B53E481Q34620604-A20F70A9-7F1D-4624-8D13-982993DA5E35Q34623471-D215A9F6-5F7C-4C7C-B7FA-2A8F8C5AC3E4Q34914164-B6795F6A-5F56-4A91-9A2F-9C081B95984FQ35050404-5FF58133-88E6-4BE2-91D4-8F23E8E5117EQ35104846-AD67BAB1-561A-4B85-911B-0252BD04AC88Q35109744-F779C0E3-A769-45CB-B0B3-3BDD63B0D772Q35111555-9C01A07B-37D9-4570-8A9B-1774E9893FADQ35215184-3A6F3C81-11FF-4980-95B0-7C439FCB7654Q35355066-4342A527-A184-4B48-8068-BBD8ED291EBAQ35534800-B1E92C1C-F16B-4894-B514-755024E2DBEDQ35543413-94EAE9F3-E782-4C79-9DFF-BB70D9BB7769Q35630843-B1B33431-1570-478D-8E7A-9255657DB56EQ35741754-39C473A9-1DC6-43B7-B0BF-FEE86B8502CBQ35741761-A6B1974F-3239-4B98-8A9B-FC3DB5E210B8Q35810679-9E6CA561-9ED0-4D89-9F8D-4FEBA3C3F348Q35819237-8816A330-DFA5-417F-B6D0-5DD4C80F624AQ35824621-63865092-B44C-4F8F-AD08-509D3114336AQ35858095-AB078F77-75AB-4FBF-B8E0-9C1CAF71A4CBQ35866744-210BDC91-BA5D-4CB8-B144-7799B63C9168Q35884715-0AB58DBC-EFBA-4501-B295-B3E5A6B06567Q35958812-0C0D7D52-B6BA-451B-BF66-B44E458E49ABQ35976708-F681FDB6-53C1-4CDB-8562-0601BF370820Q36007826-5A346723-233B-4AA4-8561-691C94B489B5Q36062457-911626DD-7041-48C3-8030-DE6976C41AC7Q36237929-41D74BF2-065B-4C41-BEA7-810FA242B331Q36329786-050F6C6D-0C69-419B-B911-B10A4F81DCE0Q36348658-7CBD72AD-16C2-48A7-A8F3-F492AB50B7C0Q36379694-25FD847E-7D36-43C1-8987-001F35E82C96Q36675859-426537CA-756F-46C3-80DC-B0C4B2531BABQ36750808-396D077C-AFD7-440F-8C2F-AE6F62DA04CB
P2860
Insulin resistance as the core defect in type 2 diabetes mellitus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin resistance as the core defect in type 2 diabetes mellitus.
@ast
Insulin resistance as the core defect in type 2 diabetes mellitus.
@en
Insulin resistance as the core defect in type 2 diabetes mellitus.
@nl
type
label
Insulin resistance as the core defect in type 2 diabetes mellitus.
@ast
Insulin resistance as the core defect in type 2 diabetes mellitus.
@en
Insulin resistance as the core defect in type 2 diabetes mellitus.
@nl
prefLabel
Insulin resistance as the core defect in type 2 diabetes mellitus.
@ast
Insulin resistance as the core defect in type 2 diabetes mellitus.
@en
Insulin resistance as the core defect in type 2 diabetes mellitus.
@nl
P1476
Insulin resistance as the core defect in type 2 diabetes mellitus.
@en
P2093
Barry J Goldstein
P304
P356
10.1016/S0002-9149(02)02553-5
P407
P577
2002-09-01T00:00:00Z